Screener
Jazz Pharmaceuticals JAZZ Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001232524-26-000025
| Line item | March 31, 2026 / Remaining Weighted-Average Useful Life(In years) | March 31, 2026 / Gross Carrying Amount | March 31, 2026 / Accumulated Amortization | March 31, 2026 / Net Book Value | December 31, 2025 / Gross Carrying Amount | December 31, 2025 / Accumulated Amortization | December 31, 2025 / Net Book Value |
|---|---|---|---|---|---|---|---|
| Acquired developed technologies | 6.6 | $8,092.6 | $(3,888.8) | $4,203.8 | $8,194.6 | $(3,765.1) | $4,429.5 |
| Manufacturing contracts | — | 1.3 | (1.3) | — | 12.6 | (12.6) | — |
| Trademarks | — | 2.9 | (2.9) | — | 2.9 | (2.9) | — |
| Total finite-lived intangible assets | $8,096.8 | $(3,893.0) | $4,203.8 | $8,210.1 | $(3,780.6) | $4,429.5 |
Item 1.Financial Statements
FAQ
- What is Jazz Pharmaceuticals's intangibles (net)?
- Jazz Pharmaceuticals (JAZZ) reported intangibles (net) of $4.2B in Q1 2026.
- How has Jazz Pharmaceuticals's intangibles (net) changed year-over-year?
- Jazz Pharmaceuticals's intangibles (net) decreased by 10.9% year-over-year, from $4.72B to $4.2B.
- What is the long-term trend for Jazz Pharmaceuticals's intangibles (net)?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's intangibles (net) has grown at a 15.1% compound annual growth rate (CAGR), from $2.2B to $4.43B.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about Jazz Pharmaceuticals's intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude